What questions are on the IIEF-5 and how do scores map to erectile dysfunction severity?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
The IIEF-5 is a validated, abridged five-item questionnaire derived from the 15‑item International Index of Erectile Function and is used to screen for the presence and grade the severity of erectile dysfunction (ED) [1]. The instrument yields a summed score from 5 to 25 with well‑established cut points that map to five severity categories and a diagnostic cutoff score of 21 to discriminate ED from no ED [1] [2].
1. What the IIEF‑5 is and why clinicians use it
The IIEF‑5 was developed as a brief, clinically practical tool to identify ED and estimate its severity by selecting five items from the full IIEF that best capture erectile function and intercourse satisfaction, producing an efficient diagnostic screen for both research and routine care [1] [2]. Validation work showed the IIEF‑5 has strong diagnostic performance — for example a receiver operating characteristic analysis in the original development study reported sensitivity of 0.98 and specificity of 0.88 using a cutoff score of 21 for discriminating ED from no ED — supporting its use as a screening and outcome instrument [1].
2. How the questionnaire is scored
Each of the five items is rated on an ordinal scale (commonly 1 to 5, from “almost never/never” to “almost always/always”), and the IIEF‑5 score is the simple sum of those five responses, yielding a total between 5 and 25 [3] [2]. Higher totals indicate better erectile function, and the instrument’s numeric simplicity is one reason it is widely adopted in epidemiologic studies and clinic assessments [4] [5].
3. How scores map to erectile dysfunction severity
Accepted interpretation brackets classify total scores as follows: 22–25 = no ED, 17–21 = mild ED, 12–16 = mild to moderate ED, 8–11 = moderate ED, and 5–7 = severe ED — these cut points come from the instrument’s creators and are reproduced in clinical reference materials [1] [6] [2]. The original development paper explicitly reported ED severity classified across those five levels and used 21 as the optimal discrimination point between ED and no ED [1].
4. What the IIEF‑5 can and cannot do — strengths and limitations
The IIEF‑5 is validated, easy to administer, and suitable for large studies and clinical follow‑up, and population research using the tool has produced prevalence and age‑trend data consistent with broader literature [7] [8]. However, it is a screening and severity‑grading instrument rather than a diagnostic probe into pathophysiology: studies caution that the IIEF‑5 should not be used alone to determine the underlying cause of ED (for example it cannot reliably differentiate vasculogenic from other etiologies) and results should be interpreted in the context of clinical history and examination [8].
5. Notes on exact question wording and practical use
While multiple clinical sources describe the IIEF‑5’s focus (items drawn from erectile function and intercourse satisfaction domains) and scoring rules, the exact item wording was not included in the snippets supplied here, and therefore exact question text cannot be reproduced from these sources in this report [1] [3]. Clinicians and investigators typically use standardized, copyrighted questionnaires or validated clinic handouts to ensure consistent wording and scoring; the supplied references document scoring, cutoffs, and validation metrics but do not provide the verbatim item list in the excerpts provided [1] [2].